Open AccessA phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling
Author(s) -
P. K. Julka,
R. T. Chacko,
S. Nag,
R. Parshad,
A. Nair,
Daniel Oh,
Zhiyuan Hu,
C. B. Koppiker,
S. Nair,
R. Dawar,
N. Dhindsa,
I. D. Miller,
D. Ma,
B. Lin,
B. Awasthy,
Charles M. Perou
Publication year - 2008
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/yt2b-bv06
Subject(s) - gemcitabine , cisplatin , medicine , oncology , breast cancer , doxorubicin , neoadjuvant therapy , chemotherapy , phases of clinical research , cancer